Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo M Horlings

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Nature Communications|November 7, 2024
An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancerYuan Gao, Sofia Ventura-Diaz, Xin Wang, et al.
Breast Cancer Research : BCR|August 9, 2019
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytesMarcelo Sobral-Leite, Izhar Salomon, Mark Opdam, et al.
JAMA Oncology|June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With ChemotherapyVeerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
Cell|January 1, 2019
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human MelanomaHanjie Li, Anne M van der Leun, Ido Yofe, et al.
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
NPJ Breast Cancer|October 21, 2021
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal womenStacey E P Joosten, Marius Wellenstein, Rutger Koornstra, et al.
Nature Communications|November 7, 2024
An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancerYuan Gao, Sofia Ventura-Diaz, Xin Wang, et al.
Breast Cancer Research : BCR|August 9, 2019
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytesMarcelo Sobral-Leite, Izhar Salomon, Mark Opdam, et al.
JAMA Oncology|June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With ChemotherapyVeerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.
Breast Cancer Research : BCR|October 4, 2023
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancerTessa G Steenbruggen, Denise M Wolf, Michael J Campbell, et al.
British Journal of Cancer|April 1, 2022
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor eraBenoit You, Lilian Van Wagensveld, Michel Tod, et al.
Cell|January 1, 2019
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human MelanomaHanjie Li, Anne M van der Leun, Ido Yofe, et al.
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Nature|August 17, 2017
Identification of CMTM6 and CMTM4 as PD-L1 protein regulatorsRiccardo Mezzadra, Chong Sun, Lucas T Jae, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
Pageof 11